Monoclonal antibody drug superior to chemotherapy for advanced acute lymphoblastic leukemia

(University of Texas M. D. Anderson Cancer Center) A Phase III clinical trial involving 101 centers in 21 countries revealed the monoclonal antibody blinatumomab to be more effective than standard chemotherapy for treatment of advanced acute lymphoblastic leukemia (ALL). Study findings were published in the March 1 online issue of the New England Journal of Medicine.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news